Business Wire
BusinessEli Lilly’s reported $2.9B Merida acquisition sparks M&A chatter as SLS and IBRX rebound after AugustThe Apex TimesBusinessElon Musk’s chip preference spotlights Nvidia’s edge over AMD, but investors still watch executionThe Apex TimesBusinessTesla shares outpaced Rivian and Chinese EV rivals in August as Robotaxi rollout inched higher, traders looked ahead to the next Cybercab pushThe Apex TimesBusinessModerna shares surge 156% in August as investors bet on clinical progressThe Apex TimesBusinessMing-Chi Kuo says Nvidia has revived Rubin CPX after it seemingly vanished from the AI roadmapThe Apex TimesBusinessApple’s next CEO arrives with a different kind of power: money, and an AI testThe Apex TimesBusinessTesla and Einride set first 2026 delivery timeline for 500 Semi trucksThe Apex TimesBusinessZonPrep buys inbound-inventory software and services, betting on Amazon logistics automationThe Apex TimesBusinessNvidia pauses part of its AI customer financing after a strong quarter, raising questions about timingThe Apex TimesBusinessBoeing Teams With Thailand’s Civil Aviation Authority to Roll Out Competency-Based Pilot Training Across the CountryThe Apex TimesBusinessApple CEO transition hands AI test to John Ternus as AAPL slipsThe Apex TimesBusinessAnthropic reportedly signs $35 billion cloud deal involving Nvidia-backed Lambda and a Texas data-center leaseThe Apex TimesBusinessEli Lilly’s reported $2.9B Merida acquisition sparks M&A chatter as SLS and IBRX rebound after AugustThe Apex TimesBusinessElon Musk’s chip preference spotlights Nvidia’s edge over AMD, but investors still watch executionThe Apex TimesBusinessTesla shares outpaced Rivian and Chinese EV rivals in August as Robotaxi rollout inched higher, traders looked ahead to the next Cybercab pushThe Apex TimesBusinessModerna shares surge 156% in August as investors bet on clinical progressThe Apex TimesBusinessMing-Chi Kuo says Nvidia has revived Rubin CPX after it seemingly vanished from the AI roadmapThe Apex TimesBusinessApple’s next CEO arrives with a different kind of power: money, and an AI testThe Apex TimesBusinessTesla and Einride set first 2026 delivery timeline for 500 Semi trucksThe Apex TimesBusinessZonPrep buys inbound-inventory software and services, betting on Amazon logistics automationThe Apex TimesBusinessNvidia pauses part of its AI customer financing after a strong quarter, raising questions about timingThe Apex TimesBusinessBoeing Teams With Thailand’s Civil Aviation Authority to Roll Out Competency-Based Pilot Training Across the CountryThe Apex TimesBusinessApple CEO transition hands AI test to John Ternus as AAPL slipsThe Apex TimesBusinessAnthropic reportedly signs $35 billion cloud deal involving Nvidia-backed Lambda and a Texas data-center leaseThe Apex TimesBusinessEli Lilly’s reported $2.9B Merida acquisition sparks M&A chatter as SLS and IBRX rebound after AugustThe Apex TimesBusinessElon Musk’s chip preference spotlights Nvidia’s edge over AMD, but investors still watch executionThe Apex TimesBusinessTesla shares outpaced Rivian and Chinese EV rivals in August as Robotaxi rollout inched higher, traders looked ahead to the next Cybercab pushThe Apex TimesBusinessModerna shares surge 156% in August as investors bet on clinical progressThe Apex TimesBusinessMing-Chi Kuo says Nvidia has revived Rubin CPX after it seemingly vanished from the AI roadmapThe Apex TimesBusinessApple’s next CEO arrives with a different kind of power: money, and an AI testThe Apex TimesBusinessTesla and Einride set first 2026 delivery timeline for 500 Semi trucksThe Apex TimesBusinessZonPrep buys inbound-inventory software and services, betting on Amazon logistics automationThe Apex TimesBusinessNvidia pauses part of its AI customer financing after a strong quarter, raising questions about timingThe Apex TimesBusinessBoeing Teams With Thailand’s Civil Aviation Authority to Roll Out Competency-Based Pilot Training Across the CountryThe Apex TimesBusinessApple CEO transition hands AI test to John Ternus as AAPL slipsThe Apex TimesBusinessAnthropic reportedly signs $35 billion cloud deal involving Nvidia-backed Lambda and a Texas data-center leaseThe Apex TimesBusinessEli Lilly’s reported $2.9B Merida acquisition sparks M&A chatter as SLS and IBRX rebound after AugustThe Apex TimesBusinessElon Musk’s chip preference spotlights Nvidia’s edge over AMD, but investors still watch executionThe Apex TimesBusinessTesla shares outpaced Rivian and Chinese EV rivals in August as Robotaxi rollout inched higher, traders looked ahead to the next Cybercab pushThe Apex TimesBusinessModerna shares surge 156% in August as investors bet on clinical progressThe Apex TimesBusinessMing-Chi Kuo says Nvidia has revived Rubin CPX after it seemingly vanished from the AI roadmapThe Apex TimesBusinessApple’s next CEO arrives with a different kind of power: money, and an AI testThe Apex TimesBusinessTesla and Einride set first 2026 delivery timeline for 500 Semi trucksThe Apex TimesBusinessZonPrep buys inbound-inventory software and services, betting on Amazon logistics automationThe Apex TimesBusinessNvidia pauses part of its AI customer financing after a strong quarter, raising questions about timingThe Apex TimesBusinessBoeing Teams With Thailand’s Civil Aviation Authority to Roll Out Competency-Based Pilot Training Across the CountryThe Apex TimesBusinessApple CEO transition hands AI test to John Ternus as AAPL slipsThe Apex TimesBusinessAnthropic reportedly signs $35 billion cloud deal involving Nvidia-backed Lambda and a Texas data-center leaseThe Apex Times
Back to front
Netflix confirms production of medical drama “First Doctor,” expanding its Korean slate
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 22, 9:26 PM EDT

Netflix confirms production of medical drama “First Doctor,” expanding its Korean slate

The streaming company says it has moved forward with the gritty medical series “First Doctor,” bringing a star-studded ensemble and fresh storytelling to its global lineup.

Netflix has confirmed it is producing the medical drama “First Doctor,” indicating an additional commitment to original Korean-language programming.

In a new post on its Newsroom, the company said the series is now in production and described the show as a “gritty” look at the pressures of life in medical settings. While Netflix did not outline a full plot summary in the announcement, it positioned the program around frontline medical stakes and character-driven conflict.

Netflix’s release highlights a major casting lineup, naming Jung Ryeo-Won, Ha Yoon-Kyoung, Bek Hyun-Jin, Kim Jong-Soo, and Kim Moo-Yul as part of the series. The company framed the ensemble as a “powerhouse cast,” which suggests Netflix expects the chemistry and performance range of the group to carry the series beyond basic genre appeal.

For Netflix, production confirmations are typically the first tangible milestone that indicates more than development, indicating that creative teams have advanced to pre-production and filming stages. Netflix’s announcement does not provide technical details such as shooting schedule, episode count, or production timeline in the excerpt available here.

Netflix did not disclose any premiere date, rating classification, or distribution specifics in the post. It also did not share whether the series will be released all at once or on a weekly basis, information that often matters to viewership strategy for timed releases.

The announcement comes as Netflix continues to lean on international original content, with Korean dramas remaining a core growth engine for the company’s global subscriber base. Korean titles have repeatedly helped expand audiences across regions, and Netflix’s ongoing investment in new Korean series reflects the value the company places on established storytelling talent and genre familiarity.

Sector observers will also note that medical dramas are a durable programming category with broad demographics, blending workplace intensity with longer arcs around patient cases and personal decisions. By adding “First Doctor” to its lineup, Netflix is effectively betting that viewers will respond not only to the genre but to the specific tone Netflix described as gritty.

Still, several details remain unclear. Netflix did not provide a synopsis, episode count, creative team credits (such as writers or directors), or information about where the series will fit in its broader 2026 release calendar. Those elements will be important for judging how Netflix intends to market the show and how it differentiates from other medical dramas.

Netflix’s next step will be to release additional production updates and, ultimately, a first-look teaser or full series description. Viewers and industry watchers will likely track casting announcements for any additional roles, as well as official timing closer to premiere.

Why It Matters

  • The move adds another Korean original to Netflix’s programming pipeline, reinforcing the company’s strategy of investing in international series.
  • A new medical drama can broaden genre reach beyond romance and thriller-heavy slates, helping Netflix diversify content for global audiences.
  • Production confirmation is an early announcement of Netflix’s near-term slate planning, which can affect how the company allocates marketing and regional promotion.
  • The presence of multiple prominent cast members suggests Netflix intends to lean on performance-driven appeal rather than only on genre branding.

Sources

Key Facts

  • Netflix confirmed production of the medical series “First Doctor” through its Newsroom.
  • Netflix described the show as a gritty medical drama focused on frontline life.
  • Netflix named Jung Ryeo-Won, Ha Yoon-Kyoung, Bek Hyun-Jin, Kim Jong-Soo, and Kim Moo-Yul as cast members.
  • The announcement did not include a premiere date, release pattern, episode count, or plot synopsis in the information available here.
  • The post also did not provide additional production specifics such as filming dates or creative team credits.

Technology Related

Sep 1, 12:07 AM EDT
The Apex Times

Apple CEO transition hands AI test to John Ternus as AAPL slips

John Ternus takes over as Apple’s chief executive role as Phil Schiller steps back, with market attention focused on how leadership changes could affect ongoing work on artificial intelligence initiatives. Apple shares slid in early trading following the transition reports.

Apple CEO transition hands AI test to John Ternus as AAPL slips
The Apex Times
Netflix confirms production of medical drama “First Doctor,” expanding its Korean slate | The Apex Times